Pyrimidine-2,4,6-trione metalloproteinase inhibitors
CA 2425280 A1 · Owner: Pfizer Products Inc. · Inventors: Wythes, Martin James; Noe, Mark Carl; Reiter, Lawrence Alan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula (I) wherein X Y, A, B and R1 are as defined in the , specification and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.